[18F]AlF-PSMA-N5

N/A

Report date: 2025/09/15 17:34:06

NME

Base Information

Drug Name[18F]AlF-PSMA-N5

Drug Alias Name[18F]AlF-PSMA-N5

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsPositron-emission tomography enhancersIonising radiation emitters

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAnhui Provincial Hospital

China Registration ClassN/A

Develop Information

Active CompaniesAnhui Provincial Hospital

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A